Ignite Creation Date:
2024-05-06 @ 3:46 PM
Last Modification Date:
2024-10-26 @ 1:56 PM
Study NCT ID:
NCT04745689
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-12-15
First Post:
2020-12-16
Brief Title:
Study of AZD2811 Durvalumab in ES-SCLC
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-23
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-03-31
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-16
First Submit QC Date:
February 8 2021
Study First Post Date:
2021-02-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-14
Last Update Post Date:
2022-12-15
Last Update Post Date Type:
ACTUAL